US Edition
Why this top broker expects CSL shares to surge 26%
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Why this top broker expects CSL shares to surge 26%
CSL Ltd (ASX: CSL) shares look well-placed to shake-off the past year's decline and charge higher into 2026. That's according to Morgans Financial, which labelled the S&P/ASX 200 Index (ASX: XJO) biotech stock "materially undervalued". CSL shares closed down 0.62% on Friday, trading for $240.92 apiece. That sees shares in the ASX 200 biotech stock down a painful 20.24% since this time last year. Those losses will have been modestly eased by the …
Morris & Garritano Named a Top 100 U.S. Insurance Broker
Morris & Garritano Insurance is honored to announce its inclusion in Business Insurance’s 2025 list of the Top 100 Largest Brokers of U.S. Business, ranking at #99. This marks the agency’s first time being recognized on the prestigious national list. Business Insurance is a respected industry publication and resource covering trends and insights for leaders in risk management, brokerage and commercial insurance. The milestone is a point of pride…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
